sleep apnea and glp 1 GLP-1 medications for apnea: potential benefits Will GLP-1 Drugs Disrupt the

Almqvist 4 , T

During 6 weeks of feeding rats with P

Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes

Clinical trials of semaglutide (Ozempic/Wegovy) show an average weight loss of 15% to 17% of total body weight over 68 weeks (approximately 16 months)

Zhang HM, Li ZY, Dai ZT, Wang J, Li LW, Zong QB

Wellness Injections for our Denver patients offer a quick and efficient way to replenish essential nutrients and support your bodys natural functions